Literature DB >> 23966484

Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation.

K V Sullivan1, N N Turner, S S Roundtree, S Young, C A Brock-Haag, D Lacey, S Abuzaid, D L Blecker-Shelly, C D Doern.   

Abstract

Assays that expedite the reporting of organism identification and antibiotic susceptibility status in positive blood cultures can fast track interventions that improve clinical outcomes. We evaluated the Verigene Gram-positive blood culture nucleic acid test (BC-GP) in two pediatric hospitals. Positive BacT/Alert Pediatric FAN blood cultures with Gram-positive organisms were tested using the BC-GP in tandem with routine laboratory procedures. To test organisms underrepresented in the clinical blood culture evaluation, blood culture bottles were spiked with diluted organism suspensions at concentrations of 10 to 100 CFU per milliliter. A total of 249 Gram-positive bacterial isolates were recovered from 242 blood cultures. The BC-GP detected Staphylococcus aureus, methicillin-susceptible S. aureus, and methicillin-resistant S. aureus with sensitivities of 100%, 99%, and 100% and specificities of 100%, 100%, and 99.5%, respectively. The BC-GP detected Staphylococcus epidermidis, methicillin-susceptible S. epidermidis, and methicillin-resistant S. epidermidis with sensitivities of 95%, 80%, and 96%, respectively, and 100% specificity. The BC-GP correctly identified 14/15 cases of Enterococcus faecalis and Enterococcus faecium bacteremia and 9 cases of Streptococcus pneumoniae. It misidentified 5/15 clinical blood cultures with Streptococcus mitis/Streptococcus oralis and 1/3 blood cultures spiked with Streptococcus anginosus group as S. pneumoniae. The BC-GP detected a case of Streptococcus pyogenes bacteremia but failed to detect 2/3 clinical blood cultures with Streptococcus agalactiae. BC-GP's rapid accurate detection of Staphylococcus spp., E. faecium, and E. faecalis and its ability to ascertain mecA, vanA, and vanB status may expedite clinical decisions pertaining to optimal antibiotic use. False-positive S. pneumoniae results may warrant reporting of only "Streptococcus spp." when this organism is reported by the BC-GP.

Entities:  

Mesh:

Year:  2013        PMID: 23966484      PMCID: PMC3889736          DOI: 10.1128/JCM.01224-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

2.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.

Authors:  Karri A Bauer; Jessica E West; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kurt B Stevenson; Debra A Goff
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

3.  Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children.

Authors:  Maria A Carrillo-Marquez; Kristina G Hulten; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2010-05       Impact factor: 2.129

4.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

5.  Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Donald H Mahoney; Edward O Mason
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

6.  Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay.

Authors:  Paul D Stamper; Lisa Louie; Henry Wong; Andrew E Simor; Jason E Farley; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

7.  New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci.

Authors:  A Huletsky; R Giroux; V Rossbach; M Gagnon; M Vaillancourt; M Bernier; F Gagnon; K Truchon; M Bastien; F J Picard; A van Belkum; M Ouellette; P H Roy; M G Bergeron
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.

Authors:  A L Y Cheah; T Spelman; D Liew; T Peel; B P Howden; D Spelman; M L Grayson; R L Nation; D C M Kong
Journal:  Clin Microbiol Infect       Date:  2013-02-07       Impact factor: 8.067

9.  Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures.

Authors:  Linoj P Samuel; Robert J Tibbetts; Adam Agotesku; Margaret Fey; Rhonda Hensley; Frederick A Meier
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

10.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Sara E Cosgrove; George Sakoulas; Eli N Perencevich
Journal:  BMC Infect Dis       Date:  2011-10-19       Impact factor: 3.090

View more
  21 in total

1.  Performance of the Verigene Gram-positive blood culture assay for direct detection of Gram-positive organisms and resistance markers in a pediatric hospital.

Authors:  Javier Mestas; Claudia M Polanco; Susanna Felsenstein; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

2.  Evaluation of Verigene Gram-Positive Blood Culture Assay performance for bacteremic patients.

Authors:  M Dodémont; R De Mendonça; C Nonhoff; S Roisin; O Denis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-27       Impact factor: 3.267

3.  Pediatric multicenter evaluation of the Verigene gram-negative blood culture test for rapid detection of inpatient bacteremia involving gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases.

Authors:  K V Sullivan; B Deburger; S S Roundtree; C A Ventrola; D L Blecker-Shelly; J E Mortensen
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections.

Authors:  C Ward; K Stocker; J Begum; P Wade; U Ebrahimsa; S D Goldenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-14       Impact factor: 3.267

5.  The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis.

Authors:  Mhair Dekmezian; Stacy G Beal; Mary Jane Damashek; Raul Benavides; Neelam Dhiman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

6.  Evaluation of FilmArray and Verigene systems for rapid identification of positive blood cultures.

Authors:  M M Bhatti; S Boonlayangoor; K G Beavis; V Tesic
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

7.  Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures.

Authors:  Nicasio Mancini; Laura Infurnari; Nadia Ghidoli; Grazia Valzano; Nicola Clementi; Roberto Burioni; Massimo Clementi
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

8.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

9.  Targeted and highly multiplexed detection of microorganisms by employing an ensemble of molecular probes.

Authors:  Weihong Xu; Sujatha Krishnakumar; Molly Miranda; Michael A Jensen; Marilyn Fukushima; Curtis Palm; Eula Fung; Ronald W Davis; Robert P St Onge; Richard W Hyman
Journal:  Appl Environ Microbiol       Date:  2014-05-02       Impact factor: 4.792

10.  Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures.

Authors:  Raquel M Martinez; Elizabeth R Bauerle; Ferric C Fang; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.